세계 재택 주입 요법 시장 규모는 2023년 432억 달러에 달했습니다. 향후 IMARC Group은 2032년까지 시장 규모가 691억 달러에 달해 2024-2032년 사이 5.2%의 연평균 성장률(CAGR)을 기록할 것으로 예측했습니다. 만성질환 유병률 증가, 재택의료 선호도 증가, 지속적인 제품 혁신이 시장을 이끄는 주요 요인 중 하나입니다.
재택 주입 요법은 항바이러스제, 면역글로빈 등의 약물, 수액, 영양제를 펌프, 카테터, 바이알 등 다양한 장비를 통해 집에서 환자에게 정맥으로 투여하는 전문적인 치료법입니다. 감염, 암, 다발성 경화증(MS), 류마티스 관절염과 같은 만성 질환으로 장기간 또는 빈번한 수액 요법이 필요한 환자에게 권장됩니다. 재택 주입 요법은 편안함과 편리함을 제공하고 삶의 질을 향상시키며 병원 내 감염의 위험을 줄여줍니다. 또한, 환자가 필요한 의료 서비스를 받으면서도 독립성을 유지하고 치료를 통제할 수 있도록 도와줍니다. 재택 주입 요법은 주로 당뇨병, 각종 소화기 질환, 종양 질환의 치료에 매우 효과적이며, 화학요법, 수분 보충, 장내, 강심, 항감염, 영양, 통증 관리 등 다양한 치료법을 제공합니다.
암, 골관절염, 인간면역결핍바이러스(HIV), 당뇨병과 같은 만성질환을 앓고 있는 인구의 증가는 시장 성장을 촉진하는 주요 요인 중 하나입니다. 이와 함께 생명을 위협하는 질병에 걸리기 쉽고 수액 요법과 같은 정기적인 치료가 필요한 노인 인구의 증가는 시장 성장에 긍정적인 영향을 미치고 있습니다. 또한, 많은 정부 이니셔티브와 유리한 상환 정책의 시행, 장기 입원 비용의 상승으로 인해 환자들이 재택 주입 요법을 선택하도록 유도하고 있으며, 이는 시장 성장에 기여하고 있습니다. 이 외에도 편의성과 비용 효율성으로 인해 재택 의료 서비스에 대한 선호도가 변화하고 있으며, 병원 공간과 병상에 대한 수요가 증가하고 있는 것도 시장 성장을 촉진하고 있습니다. 이와 함께 오염된 기구, 침구류, 공기 중의 비말에 장시간 노출되어 발생하는 병원 내 감염(HAI)의 증가도 시장 확대에 일조하고 있습니다. 이와 더불어 전문적인 투여가 필요한 특수 약품에 대한 수요가 확대되고 있는 것도 또 다른 중요한 성장 촉진요인으로 작용하고 있습니다. 또한, 가볍고 휴대가 간편하며, 수액 치료를 정확하고 실시간으로 모니터링할 수 있는 첨단 수액 주입 시스템을 갖춘 경량화, 휴대성, 사용 편의성을 갖춘 수액 펌프의 개발 등 혁신적인 기술 발전은 시장에 유익한 성장 기회를 가져다주고 있습니다.
The global home infusion therapy market size reached US$ 43.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. The rising prevalence of chronic diseases, the increasing preference for home healthcare, and ongoing product innovations represent some of the key factors driving the market.
Home infusion therapy is a specialized medical treatment involving the administration of medication, such as antivirals or immune globin, fluids, or nutrition intravenously through various equipment, including pumps, catheters, and vials, to patients in the comfort of their homes. It is recommended for patients with infections, cancer, or chronic conditions like multiple sclerosis (MS) or rheumatoid arthritis requiring long-term or frequent infusion therapy. Home infusion therapy offers comfort and convenience, improves the quality of life, and reduces the risk of hospital-acquired infections. In addition to this, it allows patients to maintain a sense of independence and control over their treatment while still receiving the necessary medical care. Home infusion therapy is highly effective in chemotherapy and hydration, enteral, inotropic, anti-infective, nutritional, and pain management therapies that are primarily used for treating diabetes and various gastrointestinal and oncological disorders.
The rise in the number of people suffering from chronic diseases, such as cancer, osteoarthritis, human immunodeficiency viruses (HIV), and diabetes, represents one of the prime factors driving the market growth. Concurrent with this, the increase in the geriatric population prone to life-threatening diseases and requiring regular medical attention, such as infusion therapy, is positively impacting the market growth. Moreover, the implementation of numerous government initiatives and favorable reimbursement policies and the surging costs of extended hospital stays are prompting patients to opt for home infusion therapy, which, in turn, is contributing to the market growth. Besides this, the shifting preference for home healthcare services due to their convenience and cost-effectiveness and the growing need for space and beds in hospitals are strengthening the market growth. In line with this, the rising prevalence of hospital-acquired infections (HAIs) due to elongated exposure to contaminated equipment, bed linens, and air droplets is aiding in market expansion. In addition to this, the widespread demand for specialty drugs which require specialized administration is acting as another significant growth-inducing factor. Furthermore, innovative technological advancements, such as the development of lightweight, portable, and easy-to-use infusion pumps equipped with advanced drip systems for precise and real-time monitoring of IV treatments, are presenting remunerative growth opportunities for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global home infusion therapy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and application.
Infusion Pumps
Elastomeric
Electromechanical
Gravity
Others
Intravenous Sets
IV Cannulas
Needleless Connectors
The report has provided a detailed breakup and analysis of the home infusion therapy market based on the product. This includes infusion pumps (elastomeric, electromechanical, gravity, and others), intravenous sets, IV cannulas, and needleless connectors. According to the report, infusion pumps represented the largest segment.
Anti-Infective
Endocrinology
Diabetes
Others
Hydration Therapy
Athletes
Others
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceuticals
Others
A detailed breakup and analysis of the home infusion therapy market based on the application has also been provided in the report. This includes anti-infective, endocrinology (diabetes and others), hydration therapy (athletes and others), chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others. According to the report, anti-infectives accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for home infusion therapy. Some of the factors driving the North America home infusion therapy market included the expanding prevalence of cancer, HIV, and diabetes, the widespread adoption of home healthcare, and numerous technological advancements in the industry.
The report has also provided a comprehensive analysis of the competitive landscape in the global home infusion therapy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Eli Lilly and Company, Fresenius SE & Co. KGaA, ICU Medical Inc., JMS Co. Ltd., Nipro Corporation, Option Care Health Inc. (Walgreen Co.), Smiths Group plc, and Terumo Corporation. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.